Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase

BACKGROUND: Hyperbaric oxygen therapy (HBOT) is a known adjuvant for treating ischemia-related inner ear diseases. Controversies still exist in the role of HBOT in cochlear diseases. Few studies to date have investigated the cellular changes that occur in inner ears after HBOT. Nitric oxide, which i...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin, Chia-Der, Wei, I-Hua, Lai, Chih-Ho, Hsia, Te-Chun, Kao, Ming-Ching, Tsai, Ming-Hsui, Wu, Ching-Hsiang, Tsai, Mang-Hung
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3050772/
https://ncbi.nlm.nih.gov/pubmed/21342510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-12-21
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items